Visible Patient Suite
K-Number: K212896 · 2021-11-05
ApplicantVisible Patient, Sas
Decision Date2021-11-05
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent
Device Summary
Visible Patient Suite is a medical device manufactured by Visible Patient, Sas. It received FDA 510(k) clearance on 2021-11-05 under approval number K212896. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Visible Patient Suite?
Visible Patient Suite is a medical device that received FDA 510(k) clearance on 2021-11-05. It is manufactured by Visible Patient, Sas. The 510(k) number is K212896.
When was Visible Patient Suite approved by the FDA?
Visible Patient Suite received FDA 510(k) clearance on 2021-11-05, under approval number K212896.
What company makes Visible Patient Suite?
Visible Patient Suite is manufactured by Visible Patient, Sas.
What is the FDA product code for Visible Patient Suite?
The FDA product code for Visible Patient Suite is LLZ.
Related Clinical Trials
NCT07604662
Real-Time Acute Kidney Injury Perioperative Prediction Clinical Trial
NOT_YET_RECRUITING
NCT02875964
Definition of Links Between Non-invasives Methods and Intracerebral EEG With Simultaneous Recordings.
COMPLETED
NCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
ENROLLING_BY_INVITATION
NCT07475780
Radiofrequency Ablation For Recurrent Parathyroid Carcinoma
RECRUITING
Related PubMed Literature
Related Devices (Code: LLZ)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.